Log in
NASDAQ:HSAQ

Health Sciences Acquisitions Co. 2 Stock Forecast, Price & News

$11.70
0.00 (0.00 %)
(As of 12/4/2020 12:00 AM ET)
Add
Compare
Today's Range
$11.11
Now: $11.70
$11.80
50-Day Range
$10.61
MA: $11.17
$11.75
52-Week Range
$10.49
Now: $11.70
$12.50
Volume2,512 shs
Average Volume22,508 shs
Market Capitalization$239.27 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Health Sciences Acquisitions Corporation 2 intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or related business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.00 out of 5 stars


Industry, Sector and Symbol

Industry Holding & other investment offices
Sub-IndustryN/A
Current SymbolNASDAQ:HSAQ
CUSIPN/A
CIKN/A
WebN/A
Phone646-597-6980
EmployeesN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Market Cap$239.27 million
Next Earnings DateN/A
OptionableNot Optionable
$11.70
0.00 (0.00 %)
(As of 12/4/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive HSAQ News and Ratings via Email

Sign-up to receive the latest news and ratings for HSAQ and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Health Sciences Acquisitions Co. 2 (NASDAQ:HSAQ) Frequently Asked Questions

What stocks does MarketBeat like better than Health Sciences Acquisitions Co. 2?

Wall Street analysts have given Health Sciences Acquisitions Co. 2 a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Health Sciences Acquisitions Co. 2 wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Who are some of Health Sciences Acquisitions Co. 2's key competitors?

What other stocks do shareholders of Health Sciences Acquisitions Co. 2 own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Health Sciences Acquisitions Co. 2 investors own include Harbor Custom Development (HCDI), Gores Holdings V (GRSVU), FS Development (FSDC), Freeline Therapeutics (FRLN), Duck Creek Technologies (DCT), CureVac (CVAC), Checkmate Pharmaceuticals (CMPI), Burlington Stores (BURL), BigCommerce (BIGC) and KE (BEKE).

Who are Health Sciences Acquisitions Co. 2's key executives?

Health Sciences Acquisitions Co. 2's management team includes the following people:
  • Dr. Roderick T. Wong M.D., Pres, CEO & Chairman (Age 43)
  • Dr. Naveen Yalamanchi M.D., Exec. VP, CFO & Director (Age 43)
  • Ms. Alice Lee J.D., VP of Operations, Sec. and Treasurer (Age 50)
  • Ms. Stephanie A. Sirota, VP of Corp. Strategy and Corp. Communications (Age 45)

When did Health Sciences Acquisitions Co. 2 IPO?

(HSAQ) raised $139 million in an initial public offering (IPO) on Tuesday, August 4th 2020. The company issued 13,900,000 shares at $10.00 per share. Chardan and Barclays served as the underwriters for the IPO.

What is Health Sciences Acquisitions Co. 2's stock symbol?

Health Sciences Acquisitions Co. 2 trades on the NASDAQ under the ticker symbol "HSAQ."

When does Health Sciences Acquisitions Co. 2's lock-up period expire?

Health Sciences Acquisitions Co. 2's lock-up period expires on Monday, February 1st. Health Sciences Acquisitions Co. 2 had issued 13,913,044 shares in its IPO on August 4th. The total size of the offering was $139,130,440 based on an initial share price of $10.00. After the end of Health Sciences Acquisitions Co. 2's lock-up period, major shareholders and company insiders will be able to sell their shares of the company.

Who are Health Sciences Acquisitions Co. 2's major shareholders?

Health Sciences Acquisitions Co. 2's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (4.98%), Perceptive Advisors LLC (2.20%), EcoR1 Capital LLC (1.96%), Boxer Capital LLC (1.96%), Logos Global Management LP (1.47%) and Boothbay Fund Management LLC (1.26%).

Which institutional investors are buying Health Sciences Acquisitions Co. 2 stock?

HSAQ stock was acquired by a variety of institutional investors in the last quarter, including BlackRock Inc., Perceptive Advisors LLC, Boxer Capital LLC, EcoR1 Capital LLC, Logos Global Management LP, Boothbay Fund Management LLC, Polar Asset Management Partners Inc., and AWM Investment Company Inc..

How do I buy shares of Health Sciences Acquisitions Co. 2?

Shares of HSAQ can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Health Sciences Acquisitions Co. 2's stock price today?

One share of HSAQ stock can currently be purchased for approximately $11.70.

How big of a company is Health Sciences Acquisitions Co. 2?

Health Sciences Acquisitions Co. 2 has a market capitalization of $239.27 million.

How can I contact Health Sciences Acquisitions Co. 2?

Health Sciences Acquisitions Co. 2's mailing address is 412 WEST 15TH STREET FLOOR 9, NEW YORK NY, 10011. The company can be reached via phone at 646-597-6980.

This page was last updated on 12/5/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.